How Microfluidics and AI Are Advancing Single-Cell Research With Richard Hammond
The Technology Networks team attended SLAS2025 and spoke with Richard Hammond, Chief Technical Officer at Sphere Fluidics. In this video, he discusses how automation, artificial intelligence (AI) and miniaturization are revolutionizing single-cell workflows. He explores the role of microfluidics, droplet-based technology and data-driven insights in accelerating drug discovery and biopharmaceutical research.
Watch to learn more about the future of high-throughput screening and cell-based assays.